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Summary
Objective: To examine the effect of IL-1β-induced ·NO and PGE2 release by stimulated superficial and deep chondrocyte/agarose constructs
subjected to mechanical compression.
Design: Chondrocyte sub-populations were seeded separately in agarose constructs and cultured unstrained, within a 24-well tissue culture
plate, for 48 h in medium supplemented with IL-1β and/or L-N-(1-iminoethyl)-ornithine (L-NIO). In a separate experiment, superficial and deep
cell containing constructs were subjected to 15% dynamic compressive strain at 1 Hz, for 48 h, in the presence or absence of IL-1β and/or
L-NIO. Nitrite was measured using the Griess assay, PGE2 release was determined using an EIA kit and [3H]-thymidine and 35SO4
incorporation were assessed by TCA and alcian blue precipitation, respectively.
Results: The current data reveal that IL-1β significantly enhanced ·NO and PGE2 release for superficial chondrocytes, an effect reversed with
L-NIO. ·NO and PGE2 levels did not significantly change by deep cells in the presence of IL-1β and/or L-NIO. For both cell sub-populations,
IL-1β inhibited cell proliferation whereas proteoglycan synthesis was not affected. Dynamic compression inhibited the release of ·NO and
PGE2 in the presence and absence of IL-1β, for cells from both sub-populations. L-NIO reduced ·NO and enhanced PGE2 release for
superficial zone chondrocytes, an effect not observed for deep cells in response to dynamic compression. The magnitude of stimulation of
[3H]-thymidine incorporation was similar for both cell sub-populations and was not influenced by L-NIO, indicating an ·NO-independent
pathway. The dynamic compression-induced stimulation of 35SO4 incorporation was enhanced with L-NIO for IL-1β-stimulated deep cells,
indicating an ·NO-dependent pathway.
Conclusion: The present findings suggest that dynamic compression inhibits ·NO and PGE2 release in IL-1β-stimulated superficial cells via
distinct pathways, a significant finding that may contribute to the development of intervention strategies for the treatment of inflammatory joint
disorders.
© 2003 Published by Elsevier Ltd on behalf of OsteoArthritis Research Society International.
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Introduction
The progressive deterioration and loss of articular cartilage
during osteoarthritis (OA) and rheumatoid arthritis (RA)
typically involves an imbalance between the anabolic and
catabolic pathways and lead to an irreversible impairment
of cartilage structure and function1–3. Cartilage degradation
is characterised by a focal loss of the load-bearing surface
due to an upregulation of the catabolic pathways not
involved in normal mechanotransduction processes.
Many studies have demonstrated that pro-inflammatory
cytokines, such as interleukin-1 (IL-1) and tumour necrosis
factor α (TNFα), act as key mediators of cartilage degra-
dation. Associated events include suppression of matrix
synthesis, activation of metalloproteinase (MMP) activity,
free radical species production, inhibition of chondrocyte
proliferation and induction of apoptotic cell death4–8. These
catabolic effects typically involve the sequential release of
nitric oxide (·NO), a diatomic free radical, which can further
stimulate other catabolic mediators such as prostaglandin
E2 (PGE2) or reactive oxygen intermediates7,9,10.
·NO is produced by a family of enzymes, collectively
termed ·NO synthase (NOS), which includes both constitu-
tively expressed isoforms (ecNOS and nNOS) and an
inducible isoform (iNOS). The activity of all NOS isoforms
can be inhibited by structural analogues of L-arginine,
such as L-N-(1-iminoethyl)-ornithine (L-NIO)11–13. Various
studies have demonstrated the overproduction of iNOS and
·NO in OA and RA cartilage compared with normal
tissue14–18. Furthermore, a number of studies have
reported that the superficial chondrocytes synthesise ·NO
at a greater rate than deep zone cells in response to
IL-1β19–21. Moreover, it has been demonstrated recently
that ·NO mediates the inhibition of proteoglycan synthesis
in chondrocyte sub-populations22–25.
Several studies have examined the effects of physical
forces on ·NO and PGE2 release26–29. It has been demon-
strated that mechanical loading inhibits both ·NO and PGE2
release, in the presence or absence of IL-1β, in full-depth
chondrocytes13,30–34. It is known, however, that superficial
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and deep zone chondrocytes, seeded separately in
agarose constructs, exhibit a differential response to mech-
anical stimulation35. In the absence of IL-1β, dynamic
compressive strain applied at a range of physiological
frequencies altered proteoglycan synthesis and cell pro-
liferation in a sub-population dependent manner35. Using a
well-characterised cell-straining system, the present study
tests the hypothesis that dynamic compression counteracts
the IL-1β-induced synthesis of both ·NO and PGE2 by
stimulated superficial and deep chondrocytes, seeded
separately in agarose constructs.
Materials and methods
ISOLATION OF CHONDROCYTE SUB-POPULATIONS
Bovine articular chondrocytes were obtained from the
metacarpalphalangeal joints of freshly slaughtered 18-
month-old steers. Thin slices of cartilage representing the
uppermost 15–20% of the total uncalcified tissue depth, as
detailed by Lee et al.35, were removed from the proximal
joint surface. The cells isolated from these slices were
termed superficial cells. The residual cartilage tissue was
harvested taking care to avoid involvement of calcified
cartilage. The cells isolated from these slices were termed
deep cells. Representative slices of superficial and deep
tissue were fixed in 4% paraformaldehyde in 0.1 M phos-
phate buffer pH 7.2, processed to wax, sectioned and
stained with haematoxylin and safranin-O.
The cartilage slices were washed in 5 ml of Earle’s
balanced salt solutions (EBSS; Sigma Chemical Co.,
Poole, UK) and transferred to a 35 mm tissue culture dish
containing 5 ml of Dulbecco’s minimal essential medium
supplemented with 20% (v/v) foetal calf serum (FCS),
2 mM L-glutamine, 20 mM HEPES, 100 unit ml−1 penicillin,
100 µg ml−1 streptomycin and 150 µg ml−1 L-ascorbic acid
(DMEM+20% FCS; Gibco, Paisley, UK). The tissue
samples were diced finely using a scalpel and incubated at
37°C on rollers for 1 h in DMEM+20% FCS+700 unit ml−1
pronase (BDH Ltd, Poole, UK) and for a further 16 h at
37°C in DMEM+20% FCS supplemented with 100 unit ml−1
collagenase type IX (Sigma Chemical Co., Poole, UK) to
yield isolated chondrocyte sub-populations. The released
chondrocytes were passed through a 70 µm pore size cell
sieve (Falcon Ltd, Oxford, UK), washed twice in
DMEM+20% FCS and resuspended in medium to give a
final cell concentration of 8×106 cells ml−1. The total cell
yield was calculated for cells isolated separately from both
sub-populations using a haemocytometer and the trypan
blue exclusion assays.
PREPARATION OF CONSTRUCTS
The chondrocyte suspension was added to an equal
volume of molten 6% (w/v) agarose type VII (Sigma
Chemical Co., Poole, UK) in EBSS to yield a final cell
concentration of 4×106 cells ml−1 in 3% (w/v) agarose for
each sub-population. Each chondrocyte/agarose suspen-
sion was poured into sterile Perspex moulds, measuring
approximately 40×35×5 mm and allowed to gel at 4°C for
20 min. Using a sterile corer, cylindrical constructs,
measuring 5 mm in diameter and 5 mm in height, were cut
and cultured in DMEM+20% FCS at 37°C in 5% CO2 for
24 h. Superficial and deep cell containing constructs were
subsequently cultured, unstrained, within a 24-well tissue
culture plate, for 48 h in 1 ml of DMEM+20% FCS supple-
mented with 10 ng ml−1 human recombinant IL-1β
(Peprotech EC Ltd, London, UK) and/or 1 mM L-NIO
(Calbiochem–Novabiochem Ltd, Nottingham, UK), as pre-
viously described13. All constructs were additionally
incubated in the presence of 1 µ Ci ml−1 [3H]-thymidine and
10 µCi ml−1 35SO4 (both Amersham International, Amer-
sham, UK) for the assessment of chondrocyte proliferation
and proteoglycan synthesis, respectively. At the end of the
labelling period, the culture medium was removed and
frozen for subsequent analysis. Constructs were digested
with 2.8 unit ml−1 papain and 10 unit ml−1 agarase (both
Sigma Chemical Co., Poole, UK).
APPLICATION OF MECHANICAL STRAIN
A well-characterised cell-straining apparatus (Zwick
Testing Machines Ltd, Leominster, UK) was used to apply
dynamic compression to chondrocyte/agarose constructs,
as described previously13,30,35,36. Superficial and deep
cell containing constructs were transferred into a 24-well
culture plate (Costar, High Wycombe, UK) and mounted
within the apparatus. One millilitre of DMEM+20%
FCS+1 µCi ml−1 [3H]-thymidine and 10 µCi ml−1 35SO4,
supplemented with 10 ng ml−1 IL-1β and/or 1 mM L-NIO,
was introduced into each well. One group of constructs was
subjected to 15% amplitude dynamic strain (0–15%)
applied in a sinusoidal waveform at 1 Hz for 48 h. A second
group of constructs remained unstrained, but was main-
tained within the incubator of the cell-straining apparatus.
All constructs were incubated at 37°C/5% CO2 for 48 h.
BIOCHEMICAL ANALYSIS
Absolute concentrations of nitrite, a stable end-product of
·NO metabolism, were determined in the media of cultured
cells using a spectrophotometric method based on the
Griess assay, as previously described13,37. Absorbance
was measured at 550 nm and nitrite concentration was
determined by comparison with standard solutions of
sodium nitrite. PGE2 release was determined in the culture
supernatant using a high sensitivity commercially available
EIA kit (Amersham Pharmacia Biotech, Buckinghamshire,
UK), as previously described13. Each sample was
incubated with reconstituted antibody and peroxidase con-
jugate. The absorbance was measured at 450 nm, using
PGE2 diluted in assay buffer as a stock standard over the
concentration range 20–640 pg ml−1. The sensitivity of the
assay is equivalent to 16 pg ml−1. [3H]-thymidine incorpor-
ation was measured in the agarase/papain digests by 10%
(v/v) trichloroacetic acid precipitation onto filters using the
Millipore Multiscreen system (Millipore, Watford, UK), as
described previously36. 35SO4 incorporation was deter-
mined in both medium and agarase/papain digests using
the alcian blue precipitation method, as described by the
authors36. Total DNA, determined using the Hoescht 33258
method36, was used as a baseline for 35SO4 incorporation
and [3H]-thymidine incorporation.
STATISTICAL ANALYSIS
Two-way ANOVA with post hoc Bonferroni-corrected
t-tests was used to examine inter- and intra-group differ-
ences for cultured and absolute data. Unpaired Student’s
t-tests were used to examine normalised data. In all
cases, a level of 5% was considered statistically significant
(P<0.05).
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Results
CELL VIABILITY AFTER ENZYMATIC DIGESTION
Representative micrographs prepared from haematoxy-
lin and safranin-O stained sections of superficial and deep
cartilage slices are presented in Fig. 1. The total tissue
thickness was approximately 300 µm. The superficial tissue
slices were approximately 60 µm in thickness (20% of total
tissue thickness) and the deep tissue slices were approxi-
mately 240 µm in thickness (80% of total tissue thickness).
The pronase and collagenase isolation procedure resulted
in complete digestion of both the superficial and deep
tissue which yielded 31±4.1 and 69±4.4% of cells, respect-
ively. The cell viability was 96±4.4% for the superficial cells
and 98±0.7% for the deep cells, a difference which was not
statistically significant (P>0.05).
INFLUENCE OF IL-1Β ON CULTURED CELL SUB-POPULATIONS
Figure 2 illustrates the effects of IL-1β on nitrite release
by superficial and deep cells, seeded separately in un-
strained constructs cultured free-floating within a tissue
culture plate. In the absence of IL-1β, nitrite release was
significantly greater in the superficial cells than the deep
cells (P<0.001) [Fig. 2(A)]. The cytokine induced a threefold
increase (P<0.001) in the superficial cell constructs, com-
pared to a non-significant increase for the deep cell con-
structs. This resulted in a 10-fold (P<0.001) difference
in nitrite release between IL-1β-stimulated cell sub-
populations. L-NIO significantly inhibited the IL-1β-induced
nitrite release for both cell sub-populations (P<0.001 and
P<0.01, for superficial and deep cells, respectively). PGE2
release was significantly greater (P<0.05) by deep cells
compared to superficial cells cultured in the absence of
IL-1β, as illustrated in Fig. 2(B). However, PGE2 levels for
deep cells did not significantly change in the presence of
IL-1β and/or L-NIO. By contrast, IL-1β induced a threefold
increase (P<0.001) in PGE2 release for superficial cells
such that the levels measured were significantly greater
(P<0.001) when compared to the deep cells. IL-1β-induced
PGE2 release was significantly reduced in the presence of
L-NIO for the superficial cells, only (P<0.01). IL-1β inhibited
[3H]-thymidine incorporation for superficial and deep cell
constructs (P<0.001 and P<0.01, respectively) and this
Fig. 1. Photomicrograph of histological sections prepared from representative slices of superficial and deep cartilage dissected for separate
isolation of chondrocytes. Haematoxylin and safranin-O. Scale bar=50 µm.
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effect could be partially reversed with L-NIO for both cell
sub-populations [Fig. 2(C)]. By contrast, 35SO4 incorpor-
ation was not significantly affected by IL-1β, either in the
presence or absence of L-NIO, for both cell sub-populations
[Fig. 2(D)].
EFFECT OF DYNAMIC COMPRESSION ON IL-1Β-STIMULATED CELL
SUB-POPULATIONS
Absolute and normalised values for nitrite and PGE2
release, [3H]-thymidine and 35SO4 incorporation by cell
sub-populations cultured within unstrained constructs and
constructs subjected to dynamic strain are presented in
Table I and Fig. 3, respectively. In unstrained superficial
and deep cell constructs maintained within the cell-
straining apparatus, IL-1β stimulated nitrite synthesis by
72% (P<0.001) and 30% (P<0.01), respectively. This
effect was reversed by dynamic compression for both
sub-populations (both P<0.01, Table I). The magnitude of
the compression-induced inhibition of nitrite release
was significantly reduced in the presence of L-NIO for
IL-1β-stimulated superficial cells, only (P<0.05) [Fig. 3(A)].
IL-1β enhanced PGE2 release over twofold (P<0.001) in
the unstrained superficial cell constructs compared to a
minimal increase for unstrained deep cells (Table I).
Dynamic compression reduced levels of PGE2 release
both in the presence or absence of IL-1β, for superficial
and deep cells, as presented in Table I and Fig. 3B.
The presence of L-NIO enhanced compressive strain-
induced inhibition of PGE2 release for superficial cells
(P<0.05) compared to a reduction for deep cells
[Fig. 3(B)].
In unstrained and strained constructs, [3H]-thymidine
incorporation was significantly greater for deep cells
(P<0.001) compared to superficial cells (P<0.01) in the
presence and absence of IL-1β (Table I). IL-1β reduced
[3H]-thymidine incorporation in unstrained constructs for
both cell sub-populations (both P<0.001), although this
effect was partially reversed by the addition of L-NIO (both
P<0.01). For each test condition, dynamic compressive
strain enhanced [3H]-thymidine incorporation for both cell
sub-populations (Table I). However, with the exception of
IL-1β-stimulated superficial cells, the magnitude of en-
hancement by dynamic compressive strain was not signifi-
cant [Fig. 3(C)]. Furthermore, the addition of L-NIO did not
influence the strain-induced stimulation of [3H]-thymidine
incorporation. 35SO4 incorporation was greater in deep
cells than in superficial cells for all test conditions
(P<0.001, in all cases, Table I). With the exception of the
results associated with IL-1β, the increases in 35SO4 incor-
poration due to dynamic stimulation of deep cells were
statistically significant (P<0.05). By contrast, the increases
due to dynamic stimulation of superficial cells were not
found to be significant [Fig. 3(D)].
Discussion
The current study utilises the well-characterised
chondrocyte/agarose model system and dynamic compres-
sion to investigate the mechanotransduction pathways that
Fig. 2. Nitrite production (A), PGE2 synthesis (B), [3H]-thymidine incorporation (C) and 35SO4 incorporation (D) by superficial and deep cell
constructs cultured for 48 h in medium supplemented with 0 or 10 ng ml−1 of IL-1β, and/or 1 mM L-NIO. Bars represent the mean and S.E.M.
of 10–18 replicates. ANOVA with post hoc Bonferroni-corrected t-test indicates significant differences between each value as follows:
*P<0.05, **P<0.01, ***P<0.001.
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Table I
Absolute values for nitrite production, PGE2 synthesis, [3H]-thymidine incorporation and 35SO4 incorporation by chondrocyte sub-populations seeded in 3% agarose and subjected to 15%
dynamic compressive strain, at 1 Hz for 48 h
Unstrained Dynamic compressive strain (1 Hz)
Untreated 10 ng ml−1 IL-1β 10 ng ml−1 IL-1β+1 mM
L-NIO
Untreated 10 ng ml−1 IL-1β 10 ng ml−1 IL-1β+1 mM
L-NIO
Superficial Deep Superficial Deep Superficial Deep Superficial Deep Superficial Deep Superficial Deep
Nitrite release (µM) 18.9
(±0.97)
9.1
(±0.55)
31.9
(±3.64)
11.5
(±0.39)
6.9
(±0.99)
7.68
(±1.0)
13.8
(±0.68)*
6.7
(±0.91)*
18.0
(±2.21)**
7.9
(±0.65)**
6.2
(±0.86)
4.5
(±0.66)**
PGE2 release (pg.ml−1) 109.2(±11.4)
118.1
(±8.4)
241.7
(±17.4)
123.0
(±6.3)
194.8
(±32.3)
60.9
(±3.7)
87.4
(±5.5)
88.0
(±3.8)**
160
(±5.2)***
93.3
(±5.5)**
104.9
(±8.5)*
51.5
(±2.8)
[3H]-Tdr incorporation
(cpm per µg DNA)
45.0
(±3.7)
135.9
(±21.1)
15.6
(±0.98)
48.1
(±5.5)
31.6
(±5.34)
94.6
(±12.3)
62.1
(±9.23)
182.2
(±23.5)
20.9
(±1.21)**
72.3
(±10.5)
51.1
(±7.5)
140.3
(±22.6)
35SO4 incorporation (µmole
µMO4/hour/µg DNA)
0.013
(±0.0019)
0.059
(±0.0052)
0.014
(±0.0015)
0.047
(±0.0038)
0.0042
(±0.0056)
0.036
(±0.0048)
0.017
(±0.0022)
0.076
(±0.0045)*
0.017
(±0.002)
0.053
(±0.0042)
0.036
(±0.0005)
0.055
(±0.0075)*
Note: Each value represents the mean and S.E.M. of between 12 and 24 replicates from three separate experiments. ANOVA with post hoc Bonferroni-corrected t-test indicates significant
differences between unstrained and strained values as follows: *P<0.05; **P<0.01; ***P<0.01.
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involve ·NO and PGE2 in IL-1β-stimulated chondrocyte
sub-populations isolated from distinct regions of articular
cartilage. The tissue used in this study was approximately
300 µm in thickness and histological examination revealed
that the superficial tissue removed from the joint contained
zone I and a proportion of zone II cartilage, while the deep
tissue represented zone III and a proportion of zone II
cartilage (Fig. 1). The chondrocyte isolation protocol pro-
duced complete digestion of both superficial and deep
tissue, and chondrocyte viability was over 96% in both
cases. There was no evidence, therefore, for selection of
sub-populations of cells due to incomplete digestion or loss
of viability.
L-NIO was used to inhibit the IL-1β-induced ·NO and
PGE2 release in chondrocyte sub-populations. L-NIO is a
non-specific inhibitor of all the NOS isoforms, with identical
Ki values (3.9 µM) for ecNOS and iNOS38. L-NIO has been
shown not to affect chondrocyte metabolism in the absence
of IL-1β39.
The current data reveal significantly greater levels of ·NO
release by IL-1β-stimulated superficial chondrocytes, com-
pared to deep chondrocytes [Fig. 2(A)]. The effects were
reversed in the presence of the NOS inhibitor L-NIO,
suggesting that de novo synthesis of ·NO mediates the
process. These findings are in agreement with a number of
previous studies investigating cytokine stimulation of
chondrocyte sub-populations in situ or isolated and main-
tained in monolayer culture or in agarose or alginate gel
culture20–24. PGE2 release was enhanced in IL-1β-
stimulated superficial cells and the effect was partially
reversed by L-NIO, indicating that the response is mediated
by ·NO [Fig. 2(B)]. By contrast, PGE2 release by deep zone
chondrocytes was unaffected by either IL-1β or L-NIO. The
differential effect may be due to a greater responsiveness
to IL-1β by superficial cells, which are known to express
a greater number of IL-1β receptors than deep zone
chondrocytes20. Thus, the current data, together with the
previous studies cited above, indicate that the superficial
cells are a major source of ·NO and PGE2 when stimulated
with IL-1β. Accordingly, the cartilage surface may be more
susceptible to degradation mediated by catabolic factors
present within the synovial fluid during inflammatory joint
disease.
The superficial cells exhibited reduced rates of prolifer-
ation and proteoglycan synthesis compared to deep cells
[Fig. 2(C and D)], results of which are in agreement with
previous studies35,40,41. Cell proliferation was inhibited by
IL-1β for both cell sub-populations and the effect could be
partially reversed in the presence of L-NIO, suggesting that
this effect is mediated by ·NO. These findings are in
agreement with a previous study, which utilised full-depth
chondrocytes13. By contrast, proteoglycan synthesis was
not influenced by IL-1β or L-NIO in either sub-population.
These data conflict with previous studies which reported an
·NO-mediated inhibition of proteoglycan synthesis in IL-1-
stimulated bovine and human chondrocyte sub-populations
cultured in monolayer or alginate gels22,23. However, such
discrepancies may be due to differences in species or the
model systems used. Indeed it has been reported pre-
viously that proteoglycan synthesis is not influenced by ·NO
release in full-depth bovine chondrocytes cultured in
agarose constructs13.
Fig. 3. The percentage change from unstrained control values for nitrite production (A), PGE2 synthesis (B), [3H]-thymidine incorporation (C)
and 35SO4 incorporation (D) by chondrocyte sub-populations seeded in 3% agarose and subjected to 15% dynamic compression at 1 Hz in
1 ml of medium, supplemented with 0 or 10 ng ml−1 of IL-1β, either in the presence or absence of 1 mM L-NIO. Error bars represent the mean
and S.E.M. of between 12 and 24 replicates from three separate experiments. Unpaired Student’s t-test results indicate differences between
untreated and IL-1β-stimulated constructs in the presence and absence of L-NIO. Values are as follows: *P<0.05, **P<0.01, ***P<0.001.
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This study utilised a well-characterised cell-straining sys-
tem for the application of 0–15% dynamic compressive
strain to chondrocytes cultured in agarose. These values
concur with previous studies which indicate that local
strains range from 5 to 50% during prolonged static com-
pression of bovine cartilage42,43. During dynamic compres-
sion, however, these values will be reduced in both intact
cartilage and agarose, due to viscoelestic nature of both
systems. The nature of cell deformation is, however, known
to be different in agarose and in intact cartilage due to
differences in lateral confinement and osmolarity changes
associated with the presence of a charged extracellular
matrix (ECM), in situ44,45. In a previous study, cell defor-
mation on application of 15% dynamic compressive strain
was identical for both sub-populations after 24 and 72 h in
culture35. Therefore, all dynamic experiments were per-
formed between this time period. It could be argued
that beyond this period, the increasing elaboration of
ECM would lead to a changing mechanical environment
associated with the cell46.
Previous work has demonstrated that dynamic compres-
sion counteracted the effects of IL-1β on the release of ·NO
and PGE2 by full-depth chondrocytes13. A similar response
was demonstrated for both superficial and deep cells
whereby dynamic compression inhibited the release of
·NO and PGE2 in the presence and absence of IL-1β, as
presented in Table I. Furthermore, the dynamic
compression-induced inhibition of ·NO release by super-
ficial zone cells was reduced with L-NIO, implicating NOS
activity in the process [Fig. 3(A)]. By contrast, the dynamic
compression-induced inhibition of PGE2 release by IL-1β-
stimulated superficial cells was further enhanced in the
presence of L-NIO [Fig. 3(B)]. A similar super-induction of
PGE2 in the presence of NOS inhibitors has been reported
previously in IL-1β-stimulated chondrocytes cultured in
monolayer or osteoarthritic cartilage explants47,48. The
present findings suggest that IL-1β and dynamic compres-
sion influence PGE2 release in superficial cells via distinct
pathways, which may exhibit a differential dependency on
·NO. L-NIO did not influence the magnitude of dynamic
compression-induced inhibition of PGE2 release by IL-1β-
stimulated deep cells, suggesting that the process is inde-
pendent of ·NO [Fig. 3(B)]. Accordingly, it appears that
intrinsic differences in the behaviour of the cell sub-
populations exist and their response to IL-1β and dynamic
compression may occur via distinct pathways.
Dynamic compression stimulated [3H]-thymidine incor-
poration for both cell sub-populations under all test
conditions although the differences were not statistically
significant in the majority of cases (Table I). Although
absolute levels of [3H]-thymidine incorporation were signifi-
cantly greater for deep cells compared to superficial cells,
the magnitude of stimulation was similar, suggesting that
both sub-populations exhibit a similar response to dynamic
loading [Fig. 3(C)]. For both cell sub-populations the mag-
nitude of dynamic compression-induced stimulation of [3H]-
thymidine incorporation was not altered in the presence of
L-NIO, indicating an ·NO-independent pathway. 35SO4
incorporation data suggest that dynamic stimulation en-
hances proteoglycan synthesis in deep cells in the absence
of IL-1β, which is in agreement with a previous study35. The
dynamic compression-induced stimulation was enhanced
with L-NIO for IL-1β-stimulated deep cells, indicating an
·NO-dependent pathway. No significant differences in
35SO4 incorporation were detected in superficial cells when
subjected to dynamic compression.
The results of the present study should be examined in
conjunction with related previous studies, as summarised
in Table II. It is evident that the nature of the response, in
terms of ·NO, PGE2, cyclooxygenase-2 (COX-2) and gly-
cosaminoglycan (GAG), is dependent on the cell type and
mode of mechanical stimulation. It is also clear that further
studies are required to elucidate the complexity of the
intracellular signalling mechanisms. The present study
demonstrates that the superficial cells have a greater
capacity to synthesise ·NO and PGE2 and that dynamic
compression, a physiologically relevant loading regime,
can counteract these effects in IL-1β-stimulated chondro-
cytes. Thus, dynamic compression can act as an anti-
inflammatory signal in IL-1β-stimulated chondrocyte sub-
populations. As the release of ·NO and PGE2 and the
influence of dynamic compression on the two mediators
were less pronounced in deep cells, it would appear that
different intracellular signalling mechanisms are occurring
Table II
Summary of studies describing the effects of physical force on intracellular signalling molecules involved in chondrocyte
mechanotransduction
Source Cell type Mechanical stimulus Other
stimuli
Response
Reference 28 Porcine cartilage explants Static compression, 0.1 MPa stress,
24 h. Intermittent compression, 0.1,
0.5 MPa, 0.5 Hz, 24 h
·NO ↑ iNOS ↑
Reference 29 Porcine cartilage explants Intermittent compression, 0.1, 0.5 MPa,
0.5 Hz, 24 h
·NO ↑ COX-2 ↑ PGE2 ↑
Reference 26 Monolayer bovine chondrocytes Fluid induced shear stress, 2 Pa, 24 h ·NO ↑ GAG ↑
Reference 27 Monolayer human or OA
chondrocytes
Fluid induced shear stress, 2 Pa, 48 h ·NO ↑ PGE2 ↑ GAG ↑
Reference 49 Monolayer human chondrocytes Intermittent hydrostatic pressure,
10 MPa, 4 h
1 µg ml−1
LPS
NOS ↓ ·NO ↓
References
31–34
Monolayer lapine or
temporomandibular chondrocytes
Cyclic tensile strain, 0.05 Hz (20%
elongation rate)
1 ng ml−1
IL-1β
iNOS ↓ COX-2 ↓ PGE2↓
Reference 30 Bovine full-depth chondrocytes in
agarose
15% dynamic compression, 1 Hz, 48 h ·NO ↓
Reference 13 Bovine full-depth chondrocytes in
agarose
15% dynamic compression, 1 Hz, 48 h 10 ng ml−1
IL-1β
·NO ↓ PGE2 ↓
Current study Bovine superficial and deep cells
in agarose
15% dynamic compression, 1 Hz, 48 h 10 ng ml−1
IL-1β
·NO ↓ PGE2 ↓,
Superficial cells
694 T. T. Chowdhury et al.: Dynamic compression counteracts IL-1β-induced release of NO and PGE2
between superficial and deep chondrocytes. Since ·NO and
PGE2 production by articular cartilage is implicated in the
development and progression of OA, the inhibition of these
inflammatory mediators by dynamic compression is a
significant finding, which could have relevance in the
treatment or prevention of joint disorders.
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